Table 2.
Comparison of Serum Cathelicidin in Children with Ulcerative Colitis, Crohn’s Disease and Control Group
Parameters | Groups | Mean | SD | Median | Range | Statistical Analysis |
---|---|---|---|---|---|---|
Cathelicidin [ng/mL] | Ulcerative colitis (n=43) | 1073.39 | 214.52 | 1092.32 | 621.38–2028.39 | H=16.28; p=0.0003*^ |
Crohn’s disease (n=25) | 1057.63 | 176.03 | 1040.04 | 742.31–1473.33 | ||
Control group (n=20) | 890.56 | 129.37 | 918.47 | 616.46–1091.76 |
Notes: *p<0.05 when comparing ulcerative colitis and controls; ^p<0.05 when comparing Crohn’s disease and controls.